biotech

How biotech IPOs performed in the third quarter
BioPharma Dive
Tue, 10/3/23 - 10:28 am
biotech
IPOs
Adlai Nortye
RayzeBio
Neumora Therapeutics
Mira Pharmaceuticals
Turnstone Biologics
Apogee Therapeutics
Sagimet Biosciences
60 Degrees Pharma
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
Sun, 09/17/23 - 09:45 pm
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
‘It’s Like Ross Was Planning This Project.’ Perot Sr.’s HQ Finds New Life as Biotech Development
D Magazine
Thu, 08/31/23 - 11:48 am
biotech
Texas
NexPoint
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Stat
Thu, 08/24/23 - 10:25 am
Vivek Ramaswamy
2024 Presidential election
biotech
Roivant
Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?
Forbes
Wed, 08/23/23 - 11:02 am
biotech
layoffs
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Stat
Wed, 08/9/23 - 10:19 am
biotech
funding
venture capital
The Column Group
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Stat
Tue, 08/8/23 - 10:19 am
biotech
funding
venture capital
Biopharma sector still growing despite layoff wave, Stifel report finds
BioPharma Dive
Mon, 08/7/23 - 11:17 pm
biopharma
biotech
jobs
layoffs
Early-stage biotech funding on pace to drop 40% in 2023, HSBC report shows
BioPharma Dive
Sat, 07/29/23 - 10:48 pm
biotech
funding
HSBC
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Women left out of VC club fight for their identity, pulling each other up one by one
Fierce Biotech
Wed, 06/7/23 - 10:05 am
venture capital
biotech
funding
Norwest Venture Partners
women
Biotech IPOs in 2023: Shaping the Future of Innovation
Xtalks
Wed, 05/31/23 - 06:52 pm
biotech
IPOs
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
BioPharma Dive
Fri, 05/26/23 - 09:47 am
Tim Springer
Harvard
biotech
R&D
3 Key Biotech Trends for 2023 And Beyond
Motley Fool
Fri, 05/19/23 - 10:13 am
biotech
collaboration
artificial intelligence
clinical trials
drug development
So you think you can go public? Few biotechs dance with Wall Street
Fierce Biotech
Mon, 05/8/23 - 11:52 pm
biotech
IPOs
Structure Therapeutics
Mineralys Therapeutics
Coya Therapeutics
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
Fri, 04/14/23 - 10:21 am
biotech
IPOs
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Fierce Biotech
Thu, 04/13/23 - 12:03 pm
layoffs
biotech
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
Tue, 04/11/23 - 07:18 pm
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling
BioSpace
Tue, 04/11/23 - 11:44 am
biotech
FDA
Texas
legal
mifepristone
abortion pill

Pages